Trial intelligence / Profile preview

Daily vs On-Demand Sildenafil After Radical Prostatectomy

NCT01315262Phase 3Unknown

Sponsor
Vita-Salute San Raffaele University
Start
Jan 2011
Primary completion
Sep 2012
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, open-label trial of sildenafil in erectile dysfunction (ED) (2 arms), sponsored by Vita-Salute San Raffaele University. Primary endpoint: International Index of Erectile Function - Erectile Function domain at 44 weeks. Status: unknown.

02

Drugs

sildenafil
03

Conditions

erectile dysfunction (ED)

Beyond the preview

Go deeper on NCT01315262.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01315262.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call